Trade ACHV stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Achieve Life Sciences, Inc. Common Shares (ACHV) is trading at US$7.98, up 0.88% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$822.19M. Over the past 52 weeks, ACHV has traded between US$2.62 and US$8.64. On Syfe you can trade ACHV with $0 commission and add it to your watchlist.
| Previous close | US$7.91 |
|---|---|
| Market cap | US$822.19M |
| 52-week range | US$2.62 – US$8.64 |
| Volume | 2.83M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Achieve Life Sciences, Inc. Common Shares
Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
Year: 1995
Achieve Life Sciences' Cytisinicline to Unlock $760 Million Market Opportunity in Smoking Cessation, Morgan Stanley Says
Aug 13, 3:46 PM · MT Newswires
Morgan Stanley Initiates Achieve Life Sciences at Overweight, With $13 Price Target
Aug 13, 9:35 AM · MT Newswires
Achieve Life Sciences Receives FDA Complete Response Letter for Cytisinicline
Jun 22, 2:40 PM · MT Newswires
Canaccord Genuity Initiates Coverage on Achieve Life Sciences With Buy Rating, $13 Price Target
Apr 21, 11:09 AM · MT Newswires
Achieve Life Sciences Launches Up to $354 Million Private Placement; Names Andrew Goldberg CEO; Shares Rise
Apr 16, 1:36 PM · MT Newswires
Stay on top of ACHV
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
